The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cognition-Enhancing Drugs Market Research Report 2025
Synopsis
Cognition-enhancing drugs are purported to improve mental functions such as cognition, memory, intelligence, motivation, attention and concentration.
The global Cognition-Enhancing Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cognition-Enhancing Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cognition-Enhancing Drugs.
Report Scope
The Cognition-Enhancing Drugs market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cognition-Enhancing Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cognition-Enhancing Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Accelerated Intelligence
Cognition Therapeutics
Cogstate
HVMN
Biogen Idec
Segment by Type
Oral
Injection
Segment by Application
Hospital Pharmacies
Drug Stores
Retail Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cognition-Enhancing Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cognition-Enhancing Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Cognition-enhancing drugs are purported to improve mental functions such as cognition, memory, intelligence, motivation, attention and concentration.
The global Cognition-Enhancing Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cognition-Enhancing Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cognition-Enhancing Drugs.
Report Scope
The Cognition-Enhancing Drugs market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cognition-Enhancing Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cognition-Enhancing Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Accelerated Intelligence
Cognition Therapeutics
Cogstate
HVMN
Biogen Idec
Segment by Type
Oral
Injection
Segment by Application
Hospital Pharmacies
Drug Stores
Retail Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cognition-Enhancing Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cognition-Enhancing Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Cognition-Enhancing Drugs Market Overview
1.1 Product Overview and Scope of Cognition-Enhancing Drugs
1.2 Cognition-Enhancing Drugs Segment by Type
1.2.1 Global Cognition-Enhancing Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Oral
1.2.3 Injection
1.3 Cognition-Enhancing Drugs Segment by Application
1.3.1 Global Cognition-Enhancing Drugs Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Retail Pharmacies
1.4 Global Cognition-Enhancing Drugs Market Size Estimates and Forecasts
1.4.1 Global Cognition-Enhancing Drugs Revenue 2019-2030
1.4.2 Global Cognition-Enhancing Drugs Sales 2019-2030
1.4.3 Global Cognition-Enhancing Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Cognition-Enhancing Drugs Market Competition by Manufacturers
2.1 Global Cognition-Enhancing Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Cognition-Enhancing Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Cognition-Enhancing Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Cognition-Enhancing Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cognition-Enhancing Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cognition-Enhancing Drugs, Product Type & Application
2.7 Cognition-Enhancing Drugs Market Competitive Situation and Trends
2.7.1 Cognition-Enhancing Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cognition-Enhancing Drugs Players Market Share by Revenue
2.7.3 Global Cognition-Enhancing Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cognition-Enhancing Drugs Retrospective Market Scenario by Region
3.1 Global Cognition-Enhancing Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Cognition-Enhancing Drugs Global Cognition-Enhancing Drugs Sales by Region: 2019-2030
3.2.1 Global Cognition-Enhancing Drugs Sales by Region: 2019-2024
3.2.2 Global Cognition-Enhancing Drugs Sales by Region: 2025-2030
3.3 Global Cognition-Enhancing Drugs Global Cognition-Enhancing Drugs Revenue by Region: 2019-2030
3.3.1 Global Cognition-Enhancing Drugs Revenue by Region: 2019-2024
3.3.2 Global Cognition-Enhancing Drugs Revenue by Region: 2025-2030
3.4 North America Cognition-Enhancing Drugs Market Facts & Figures by Country
3.4.1 North America Cognition-Enhancing Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Cognition-Enhancing Drugs Sales by Country (2019-2030)
3.4.3 North America Cognition-Enhancing Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cognition-Enhancing Drugs Market Facts & Figures by Country
3.5.1 Europe Cognition-Enhancing Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Cognition-Enhancing Drugs Sales by Country (2019-2030)
3.5.3 Europe Cognition-Enhancing Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cognition-Enhancing Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Cognition-Enhancing Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Cognition-Enhancing Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Cognition-Enhancing Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cognition-Enhancing Drugs Market Facts & Figures by Country
3.7.1 Latin America Cognition-Enhancing Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Cognition-Enhancing Drugs Sales by Country (2019-2030)
3.7.3 Latin America Cognition-Enhancing Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cognition-Enhancing Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Cognition-Enhancing Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Cognition-Enhancing Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Cognition-Enhancing Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Cognition-Enhancing Drugs Sales by Type (2019-2030)
4.1.1 Global Cognition-Enhancing Drugs Sales by Type (2019-2024)
4.1.2 Global Cognition-Enhancing Drugs Sales by Type (2025-2030)
4.1.3 Global Cognition-Enhancing Drugs Sales Market Share by Type (2019-2030)
4.2 Global Cognition-Enhancing Drugs Revenue by Type (2019-2030)
4.2.1 Global Cognition-Enhancing Drugs Revenue by Type (2019-2024)
4.2.2 Global Cognition-Enhancing Drugs Revenue by Type (2025-2030)
4.2.3 Global Cognition-Enhancing Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Cognition-Enhancing Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Cognition-Enhancing Drugs Sales by Application (2019-2030)
5.1.1 Global Cognition-Enhancing Drugs Sales by Application (2019-2024)
5.1.2 Global Cognition-Enhancing Drugs Sales by Application (2025-2030)
5.1.3 Global Cognition-Enhancing Drugs Sales Market Share by Application (2019-2030)
5.2 Global Cognition-Enhancing Drugs Revenue by Application (2019-2030)
5.2.1 Global Cognition-Enhancing Drugs Revenue by Application (2019-2024)
5.2.2 Global Cognition-Enhancing Drugs Revenue by Application (2025-2030)
5.2.3 Global Cognition-Enhancing Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Cognition-Enhancing Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Accelerated Intelligence
6.1.1 Accelerated Intelligence Corporation Information
6.1.2 Accelerated Intelligence Description and Business Overview
6.1.3 Accelerated Intelligence Cognition-Enhancing Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Accelerated Intelligence Cognition-Enhancing Drugs Product Portfolio
6.1.5 Accelerated Intelligence Recent Developments/Updates
6.2 Cognition Therapeutics
6.2.1 Cognition Therapeutics Corporation Information
6.2.2 Cognition Therapeutics Description and Business Overview
6.2.3 Cognition Therapeutics Cognition-Enhancing Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Cognition Therapeutics Cognition-Enhancing Drugs Product Portfolio
6.2.5 Cognition Therapeutics Recent Developments/Updates
6.3 Cogstate
6.3.1 Cogstate Corporation Information
6.3.2 Cogstate Description and Business Overview
6.3.3 Cogstate Cognition-Enhancing Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cogstate Cognition-Enhancing Drugs Product Portfolio
6.3.5 Cogstate Recent Developments/Updates
6.4 HVMN
6.4.1 HVMN Corporation Information
6.4.2 HVMN Description and Business Overview
6.4.3 HVMN Cognition-Enhancing Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 HVMN Cognition-Enhancing Drugs Product Portfolio
6.4.5 HVMN Recent Developments/Updates
6.5 Biogen Idec
6.5.1 Biogen Idec Corporation Information
6.5.2 Biogen Idec Description and Business Overview
6.5.3 Biogen Idec Cognition-Enhancing Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Biogen Idec Cognition-Enhancing Drugs Product Portfolio
6.5.5 Biogen Idec Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cognition-Enhancing Drugs Industry Chain Analysis
7.2 Cognition-Enhancing Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cognition-Enhancing Drugs Production Mode & Process
7.4 Cognition-Enhancing Drugs Sales and Marketing
7.4.1 Cognition-Enhancing Drugs Sales Channels
7.4.2 Cognition-Enhancing Drugs Distributors
7.5 Cognition-Enhancing Drugs Customers
8 Cognition-Enhancing Drugs Market Dynamics
8.1 Cognition-Enhancing Drugs Industry Trends
8.2 Cognition-Enhancing Drugs Market Drivers
8.3 Cognition-Enhancing Drugs Market Challenges
8.4 Cognition-Enhancing Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Cognition-Enhancing Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Cognition-Enhancing Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Cognition-Enhancing Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Cognition-Enhancing Drugs Sales (K MT) of Key Manufacturers (2019-2024)
Table 5. Global Cognition-Enhancing Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Cognition-Enhancing Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Cognition-Enhancing Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Cognition-Enhancing Drugs Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Cognition-Enhancing Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Cognition-Enhancing Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Cognition-Enhancing Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Cognition-Enhancing Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cognition-Enhancing Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cognition-Enhancing Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cognition-Enhancing Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Cognition-Enhancing Drugs Sales by Region (2019-2024) & (K MT)
Table 18. Global Cognition-Enhancing Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Cognition-Enhancing Drugs Sales by Region (2025-2030) & (K MT)
Table 20. Global Cognition-Enhancing Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Cognition-Enhancing Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Cognition-Enhancing Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Cognition-Enhancing Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Cognition-Enhancing Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Cognition-Enhancing Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Cognition-Enhancing Drugs Sales by Country (2019-2024) & (K MT)
Table 27. North America Cognition-Enhancing Drugs Sales by Country (2025-2030) & (K MT)
Table 28. North America Cognition-Enhancing Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Cognition-Enhancing Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Cognition-Enhancing Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Cognition-Enhancing Drugs Sales by Country (2019-2024) & (K MT)
Table 32. Europe Cognition-Enhancing Drugs Sales by Country (2025-2030) & (K MT)
Table 33. Europe Cognition-Enhancing Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Cognition-Enhancing Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Cognition-Enhancing Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Cognition-Enhancing Drugs Sales by Region (2019-2024) & (K MT)
Table 37. Asia Pacific Cognition-Enhancing Drugs Sales by Region (2025-2030) & (K MT)
Table 38. Asia Pacific Cognition-Enhancing Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Cognition-Enhancing Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Cognition-Enhancing Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Cognition-Enhancing Drugs Sales by Country (2019-2024) & (K MT)
Table 42. Latin America Cognition-Enhancing Drugs Sales by Country (2025-2030) & (K MT)
Table 43. Latin America Cognition-Enhancing Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Cognition-Enhancing Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Cognition-Enhancing Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Cognition-Enhancing Drugs Sales by Country (2019-2024) & (K MT)
Table 47. Middle East & Africa Cognition-Enhancing Drugs Sales by Country (2025-2030) & (K MT)
Table 48. Middle East & Africa Cognition-Enhancing Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Cognition-Enhancing Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Cognition-Enhancing Drugs Sales (K MT) by Type (2019-2024)
Table 51. Global Cognition-Enhancing Drugs Sales (K MT) by Type (2025-2030)
Table 52. Global Cognition-Enhancing Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Cognition-Enhancing Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Cognition-Enhancing Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Cognition-Enhancing Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Cognition-Enhancing Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Cognition-Enhancing Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Cognition-Enhancing Drugs Price (USD/MT) by Type (2019-2024)
Table 59. Global Cognition-Enhancing Drugs Price (USD/MT) by Type (2025-2030)
Table 60. Global Cognition-Enhancing Drugs Sales (K MT) by Application (2019-2024)
Table 61. Global Cognition-Enhancing Drugs Sales (K MT) by Application (2025-2030)
Table 62. Global Cognition-Enhancing Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Cognition-Enhancing Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Cognition-Enhancing Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Cognition-Enhancing Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Cognition-Enhancing Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Cognition-Enhancing Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Cognition-Enhancing Drugs Price (USD/MT) by Application (2019-2024)
Table 69. Global Cognition-Enhancing Drugs Price (USD/MT) by Application (2025-2030)
Table 70. Accelerated Intelligence Corporation Information
Table 71. Accelerated Intelligence Description and Business Overview
Table 72. Accelerated Intelligence Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 73. Accelerated Intelligence Cognition-Enhancing Drugs Product
Table 74. Accelerated Intelligence Recent Developments/Updates
Table 75. Cognition Therapeutics Corporation Information
Table 76. Cognition Therapeutics Description and Business Overview
Table 77. Cognition Therapeutics Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 78. Cognition Therapeutics Cognition-Enhancing Drugs Product
Table 79. Cognition Therapeutics Recent Developments/Updates
Table 80. Cogstate Corporation Information
Table 81. Cogstate Description and Business Overview
Table 82. Cogstate Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 83. Cogstate Cognition-Enhancing Drugs Product
Table 84. Cogstate Recent Developments/Updates
Table 85. HVMN Corporation Information
Table 86. HVMN Description and Business Overview
Table 87. HVMN Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 88. HVMN Cognition-Enhancing Drugs Product
Table 89. HVMN Recent Developments/Updates
Table 90. Biogen Idec Corporation Information
Table 91. Biogen Idec Description and Business Overview
Table 92. Biogen Idec Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 93. Biogen Idec Cognition-Enhancing Drugs Product
Table 94. Biogen Idec Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Cognition-Enhancing Drugs Distributors List
Table 98. Cognition-Enhancing Drugs Customers List
Table 99. Cognition-Enhancing Drugs Market Trends
Table 100. Cognition-Enhancing Drugs Market Drivers
Table 101. Cognition-Enhancing Drugs Market Challenges
Table 102. Cognition-Enhancing Drugs Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Cognition-Enhancing Drugs
Figure 2. Global Cognition-Enhancing Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Cognition-Enhancing Drugs Market Share by Type in 2023 & 2030
Figure 4. Oral Product Picture
Figure 5. Injection Product Picture
Figure 6. Global Cognition-Enhancing Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Cognition-Enhancing Drugs Market Share by Application in 2023 & 2030
Figure 8. Hospital Pharmacies
Figure 9. Drug Stores
Figure 10. Retail Pharmacies
Figure 11. Global Cognition-Enhancing Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Cognition-Enhancing Drugs Market Size (2019-2030) & (US$ Million)
Figure 13. Global Cognition-Enhancing Drugs Sales (2019-2030) & (K MT)
Figure 14. Global Cognition-Enhancing Drugs Average Price (USD/MT) & (2019-2030)
Figure 15. Cognition-Enhancing Drugs Report Years Considered
Figure 16. Cognition-Enhancing Drugs Sales Share by Manufacturers in 2023
Figure 17. Global Cognition-Enhancing Drugs Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Cognition-Enhancing Drugs Players: Market Share by Revenue in 2023
Figure 19. Cognition-Enhancing Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Cognition-Enhancing Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Cognition-Enhancing Drugs Sales Market Share by Country (2019-2030)
Figure 22. North America Cognition-Enhancing Drugs Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Cognition-Enhancing Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Cognition-Enhancing Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Cognition-Enhancing Drugs Sales Market Share by Country (2019-2030)
Figure 26. Europe Cognition-Enhancing Drugs Revenue Market Share by Country (2019-2030)
Figure 27. Germany Cognition-Enhancing Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Cognition-Enhancing Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Cognition-Enhancing Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Cognition-Enhancing Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Cognition-Enhancing Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Cognition-Enhancing Drugs Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Cognition-Enhancing Drugs Revenue Market Share by Region (2019-2030)
Figure 34. China Cognition-Enhancing Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Cognition-Enhancing Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Cognition-Enhancing Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Cognition-Enhancing Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Cognition-Enhancing Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Cognition-Enhancing Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Cognition-Enhancing Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Cognition-Enhancing Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Cognition-Enhancing Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Cognition-Enhancing Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Cognition-Enhancing Drugs Sales Market Share by Country (2019-2030)
Figure 45. Latin America Cognition-Enhancing Drugs Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Cognition-Enhancing Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Cognition-Enhancing Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Cognition-Enhancing Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Cognition-Enhancing Drugs Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Cognition-Enhancing Drugs Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Cognition-Enhancing Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Cognition-Enhancing Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Cognition-Enhancing Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Cognition-Enhancing Drugs by Type (2019-2030)
Figure 55. Global Revenue Market Share of Cognition-Enhancing Drugs by Type (2019-2030)
Figure 56. Global Cognition-Enhancing Drugs Price (USD/MT) by Type (2019-2030)
Figure 57. Global Sales Market Share of Cognition-Enhancing Drugs by Application (2019-2030)
Figure 58. Global Revenue Market Share of Cognition-Enhancing Drugs by Application (2019-2030)
Figure 59. Global Cognition-Enhancing Drugs Price (USD/MT) by Application (2019-2030)
Figure 60. Cognition-Enhancing Drugs Value Chain
Figure 61. Cognition-Enhancing Drugs Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
